[Congenital erythropoietic porphyria]. 1995

K Tanigawa, and N Takamura, and S Yamashita
Department of Preventive Medicine, Nagasaki University School of Medicine.

Congenital erythropoietic porphyria (CEP, Günther's disease) is an extremely rare autosomal recessive disease (There have been only 33 case reports in Japan to date.), characterized by mutilating cutaneous photosensitivity and abnormal haem synthesis in the bone marrow. Reduced activity of uroporphyrinogen III synthase (UROIIIS), the fourth enzyme of haem biosynthetic pathway causes this disease. Recent progresses of molecular biology enable us to analyze genetic defect at the molecular level of porphyrias. Also in CEP, it has been reported several reports of mutations of the UROIIIS gene since isolation of a full-length human cDNA encoding UROIIIS by Desnick et al. Here we report about epidemiology, signs and symptoms, laboratory findings and therapies of CEP.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014576 Uroporphyrinogen III Synthetase An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield UROPORPHYRINOGEN III and water. It is the fourth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by UROS gene. Mutations of UROS gene result in CONGENITAL ERYTHROPOIETIC PORPHYRIA. Cosynthase,Uroporphyrinogen III Cosynthetase,Uroporphyrinogen Isomerase,Uroporphyrinogen-III Synthase,Cosynthetase, Uroporphyrinogen III,Isomerase, Uroporphyrinogen,Synthase, Uroporphyrinogen-III,Synthetase, Uroporphyrinogen III,Uroporphyrinogen III Synthase
D017092 Porphyria, Erythropoietic An autosomal recessive porphyria that is due to a deficiency of UROPORPHYRINOGEN III SYNTHASE in the BONE MARROW; also known as congenital erythropoietic porphyria. This disease is characterized by SPLENOMEGALY; ANEMIA; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of UROPORPHYRINS and COPROPORPHYRINS. Deficiency of Uroporphyrinogen III Synthase,Erythropoietic Porphyria,Gunther's Disease,Porphyria, Erythropoietic, Congenital,Uroporphyrinogen III Synthase, Deficiency of,Congenital Erythropoietic Porphyria,Gunther Disease,Porphyria, Congenital Erythropoietic,UROS Deficiency,Congenital Erythropoietic Porphyrias,Erythropoietic Porphyria, Congenital,Erythropoietic Porphyrias,Erythropoietic Porphyrias, Congenital,Gunthers Disease,Porphyrias, Congenital Erythropoietic,Porphyrias, Erythropoietic

Related Publications

K Tanigawa, and N Takamura, and S Yamashita
January 1998, Skin pharmacology and applied skin physiology,
K Tanigawa, and N Takamura, and S Yamashita
December 1973, Ugeskrift for laeger,
K Tanigawa, and N Takamura, and S Yamashita
January 1998, Ryoikibetsu shokogun shirizu,
K Tanigawa, and N Takamura, and S Yamashita
January 1995, Indian pediatrics,
K Tanigawa, and N Takamura, and S Yamashita
January 1987, Archivio stomatologico,
K Tanigawa, and N Takamura, and S Yamashita
April 1997, Journal of the American Academy of Dermatology,
K Tanigawa, and N Takamura, and S Yamashita
December 1979, Lakartidningen,
K Tanigawa, and N Takamura, and S Yamashita
May 1972, Canadian Medical Association journal,
K Tanigawa, and N Takamura, and S Yamashita
January 1985, The Turkish journal of pediatrics,
K Tanigawa, and N Takamura, and S Yamashita
November 1993, Indian pediatrics,
Copied contents to your clipboard!